Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status.

Gijtenbeek, Rolof Gp; de Jong, Kim; Venmans, Ben Jw; van Vollenhoven, Femke Hm; Ten Brinke, Anneke; Van der Wekken, Anthonie J; van Geffen, Wouter H

Gijtenbeek, Rolof Gp; de Jong, Kim; Venmans, Ben Jw; van Vollenhoven, Femke Hm; Ten Brinke, Anneke; Van der Wekken, Anthonie J; van Geffen, Wouter H.

Afiliação

Gijtenbeek RG; Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, Netherlands.
de Jong K; Department of Epidemiology, Medical Center Leeuwarden, Leeuwarden, Netherlands.
Venmans BJ; Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, Netherlands.
van Vollenhoven FH; Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, Netherlands.
Ten Brinke A; Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, Netherlands.
Van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
van Geffen WH; Department of Pulmonary Diseases, Medical Center Leeuwarden, Leeuwarden, Netherlands.

Cochrane Database Syst Rev ; 7: CD013382, 2023 07 07.

Article em En | MEDLINE | ID: mdl-37419867

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Humanos; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Carboplatina/uso terapêutico; Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; Carcinoma Pulmonar de Células não Pequenas/genética; Cisplatino; Neoplasias Pulmonares/tratamento farmacológico; Neoplasias Pulmonares/genética; Mutação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google